171 related articles for article (PubMed ID: 33372933)
1. Desmoid tumors: diagnostic and therapeutic considerations.
Brener-Chaoul M; Cervantes-Gutiérrez Ó; Padilla-Longoria R; Martín-Téllez KS
Gac Med Mex; 2020; 156(5):439-445. PubMed ID: 33372933
[TBL] [Abstract][Full Text] [Related]
2. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
[TBL] [Abstract][Full Text] [Related]
3. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
[TBL] [Abstract][Full Text] [Related]
5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
6. A rare sporadic pancreatic desmoid fibromatosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration: Case report and literature review.
Stone AB; Mallery JS; Stewart J; Amin K
Diagn Cytopathol; 2021 Feb; 49(2):E49-E54. PubMed ID: 32857922
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
8. Optimal therapy for desmoid tumors: current options and challenges for the future.
Al-Jazrawe M; Au M; Alman B
Expert Rev Anticancer Ther; 2015; 15(12):1443-58. PubMed ID: 26472625
[TBL] [Abstract][Full Text] [Related]
9. Adult desmoid tumors: biology, management and ongoing trials.
Penel N; Chibon F; Salas S
Curr Opin Oncol; 2017 Jul; 29(4):268-274. PubMed ID: 28489620
[TBL] [Abstract][Full Text] [Related]
10. Desmoid-Type Fibromatosis.
Garcia-Ortega DY; Martín-Tellez KS; Cuellar-Hubbe M; Martínez-Said H; Álvarez-Cano A; Brener-Chaoul M; Alegría-Baños JA; Martínez-Tlahuel JL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660036
[TBL] [Abstract][Full Text] [Related]
11. [Intraabdominal desmoid tumors in familial adenomatous polyposis].
Galletto P; Leoz ML; Castells A; Balaguer F
Gastroenterol Hepatol; 2013 Nov; 36(9):580-6. PubMed ID: 23541808
[TBL] [Abstract][Full Text] [Related]
12. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
13. Desmoid fibromatosis: is the current picture changing?
Pandrowala S; Jones RL; Gupta S; Gulia A
Future Oncol; 2021 Sep; 17(25):3397-3408. PubMed ID: 34227399
[TBL] [Abstract][Full Text] [Related]
14. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
15. A to Z of desmoid tumors.
Shinagare AB; Ramaiya NH; Jagannathan JP; Krajewski KM; Giardino AA; Butrynski JE; Raut CP
AJR Am J Roentgenol; 2011 Dec; 197(6):W1008-14. PubMed ID: 22109314
[TBL] [Abstract][Full Text] [Related]
16. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
[TBL] [Abstract][Full Text] [Related]
17. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
[TBL] [Abstract][Full Text] [Related]
18. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
[TBL] [Abstract][Full Text] [Related]
19. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
[TBL] [Abstract][Full Text] [Related]
20. [Desmoid tumors in patients with familial adenomatous polyposis].
Pikaar A; Nortier JW; Griffioen G; Vasen HF
Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1355-9. PubMed ID: 12162172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]